Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Why is this going down BIG?
YES YES YES. Not sure why they are not partner with a company already have the cash and share the wealth.
Where is the volume?
Please contact him and ask him to give us MORE INFO.
Get your 2 million shares at the current dirt cheap pps. The news will come and you will be rich.
When this news comes, pps will explode to 50 cents in a week.
HUge money in this business.
stock promotion... ready to move NORTH.
http://www.getresponse.com/archive/joescupofcoffee/Therapy-Cells-TCEL-Seeking-FDA-approval-for-treatment-64060902.html
I know 3 other stocks are hotter than this. LOW float and big news of incoming revenues.
I will try my best to play this one.
Therapy Cells Inc did not put out any misleading PR. Some investors here tricked us.
A link between Therapy Cells Inc and Therapy Cells 2000..
Press release September 12, 2011
Therapy Cells Inc. 584 Main Street Saint Helena, CA 94574 Patrick Casey BVSc, PhD, MRCVS President and founding scientist
Leading Bio-Tech Firm Moves to US
Today leading New Zealand biotechnology company Therapy Cell Ltd announced it was moving to the United States through its merger with Therapy Cells Inc (formerly DIII OTC Market). This exciting Bio Tech/Med tech Company holds the exclusive technology that allows adult cells from an individual's specific tissue (e.g. Achilles tendon) to grow again enacting repair and regeneration of that tissue. Renowned scientist Dr. Patrick (Paddy) Casey, who shares his time between the University of Auckland and labs at UC Davis, has been appointed President and Chief Scientific Officer of Therapy Cells Inc. Dr. Casey said, “To our knowledge, we are the only company in the World that has this proven technology, which is in a strong patent position and effectively by-passes the need for Stem Cell Treatment. We are very excited about entering the US market and pursuing FDA approval”. This technology has been appraised currently at an initial valuation of $30 million US dollars. Upon FDA approval for clinical use of this technology in humans will likely increase this factor by at least 10 times as much. Therapy Cells, which is headed by Dr Casey, has very strong links to the San Francisco bay area. Therapy Cells has collaborated with and has laboratories at University of California, Davis. “The natural synergy and roll out is obvious” said President/CS Dr Paddy Casey. After explaining that the safety and efficacy work of this transformational technology has been completed in the FDA approved model species for athletic injury (the horse is the recognized species for athletic injury in this case), Dr Casey says that “We are anticipating FDA approval of our process within 12 to 18 months maximum” The company can be reached at info@therapycells.com, or www.therapycells.com or Facebook page Therapy Cells. These are exciting times indeed!
They been at this for a long while so news can be drop at anytime.
Any fda approval update will put this in a dollar range. There are billions of people and this applies to humans. $$$$$$$$
According to Dr Casey, approval takes 12-18 months for this. So announcement could be anytime soon..
Press release September 12, 2011
Therapy Cells Inc. 584 Main Street Saint Helena, CA 94574 Patrick Casey BVSc, PhD, MRCVS President and founding scientist
Leading Bio-Tech Firm Moves to US
Today leading New Zealand biotechnology company Therapy Cell Ltd announced it was moving to the United States through its merger with Therapy Cells Inc (formerly DIII OTC Market). This exciting Bio Tech/Med tech Company holds the exclusive technology that allows adult cells from an individual's specific tissue (e.g. Achilles tendon) to grow again enacting repair and regeneration of that tissue. Renowned scientist Dr. Patrick (Paddy) Casey, who shares his time between the University of Auckland and labs at UC Davis, has been appointed President and Chief Scientific Officer of Therapy Cells Inc. Dr. Casey said, “To our knowledge, we are the only company in the World that has this proven technology, which is in a strong patent position and effectively by-passes the need for Stem Cell Treatment. We are very excited about entering the US market and pursuing FDA approval”. This technology has been appraised currently at an initial valuation of $30 million US dollars. Upon FDA approval for clinical use of this technology in humans will likely increase this factor by at least 10 times as much. Therapy Cells, which is headed by Dr Casey, has very strong links to the San Francisco bay area. Therapy Cells has collaborated with and has laboratories at University of California, Davis. “The natural synergy and roll out is obvious” said President/CS Dr Paddy Casey. After explaining that the safety and efficacy work of this transformational technology has been completed in the FDA approved model species for athletic injury (the horse is the recognized species for athletic injury in this case), Dr Casey says that “We are anticipating FDA approval of our process within 12 to 18 months maximum” The company can be reached at info@therapycells.com, or www.therapycells.com or Facebook page Therapy Cells. These are exciting times indeed!
some reading on Dr Casey, Therapy Cell Inc, and FDA.
http://www.horsetalk.co.nz/news/2012/03/017.shtml#axzz38d49NLeS
They have raised 2 millions or almost there for approval process.
not sure, the idea of FDA approval for this company floating around for a year or more.
FDA approval for humans will explode this stock to a dollar.
Once and for all, whomever have contacts with management, please ask them the current float, AS, etc.
This is for all of us investors.
Cheap shares. LOAD LOAD LOAD for your million. I got 2 millions.
1 million for flip and 2nd million for long.
From the CFO a day or two ago : We are concerned solely with the development of cell replacement within equine stock and are actively seeking FDA approval for the end product
Once ANY news about FDA approval, instant dollar pps. Get your million shares and HOLD.
That is fine. If it is green, check out early.
What does "check availability" number means?
the price was going green today until it got diluted. a big dump.
Please someone write to management for the time line for FDA approval.
All I know, once you have FDA approval news. this goes to easily 60 cents..
Now makes sense. The patent awarded to Dr Casy and licensd to Therapy Cell Inc for use in human applications.
Once FDA approves this, expect a rush for a dollar a share.
http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8372644.PN.&OS=PN/8372644&RS=PN/8372644
Look at the application number and patent number and check with previous pr/news release.
THIS DONT MAKE SENSE TO ME.
I did research on this "US patent US 11/702,895" and "USPatent #8,372,644" are the same thing. both point to the same patent.
To all, please clarify. Both company Therapy Cells inc and Therapy Cells 2000 own the SAME patent #8,372,644?
With huge volume in the past few days, why not maxed out?
If pps goes down, company selling shares to raise money or pay off debts.
HUMANS, HUMANS, AND AND MORE HUMANS. forget the horses.
The application for this technology in humans is huge, billion dollar industry.
If they have the science behind this, it should be approved.
Once approve by FDA, worth a dollar share.
What is the website for this company?